Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases

Kidney International, Supplement

Volumn 64, Issue 86, 2003, Pages

  Vío, Carlos P ^a   Jeanneret, Valerie A ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; SODIUM; KALLIKREIN;

CONFERENCE PAPER; DISEASE COURSE; ENZYME ACTIVITY; HEALTH STATUS; HUMAN; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY TUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SODIUM RETENTION; VASOCONSTRICTION; ANIMAL; BIOSYNTHESIS; ENZYME INDUCTION; ENZYMOLOGY; KIDNEY; METABOLISM; PHYSIOLOGY; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; DISEASE PROGRESSION; ENZYME INDUCTION; HUMANS; KALLIKREINS; KIDNEY; KIDNEY DISEASES; PEPTIDYL-DIPEPTIDASE A; TISSUE DISTRIBUTION;

EID: 17944389392     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.64.s86.11.x     Document Type: Conference Paper

References (57)

1. KLAHR S, MORRISSEY JJ: The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int (Suppl 75):S7-14, 2000
2. MEZZANO SA, RUIZ-ORTEGA M, EGIDO J: Angiotensin II and renal fibrosis. Hypertens 38:635-638, 2001
3. SIBONY M, GASC JM, SOUBRIER F, et al: Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertens 21:827-835, 1993
4. HAGAMAN JR, MOYER JS, ERIC S, et al: Angiotensin-converting enzyme and male fertility. Proc Natl Acad Sci 95:2552-2557, 1998
5. ESTHER CR, HOWARD TE, MARINO EM, et al: Mice lacking angiotensin-converting-enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74:953-965, 1996
6. JASPARD E, WEI L, ALHENC-GELAS F: Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting-enzyme (kininase II). Studies with bradykinin and other natural peptides. J Biol Chem 268:9496-9503, 1993
7. ROUSSEAU A, MICHAUD A, CHAUVET M-T, et al: The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol Chem 270:3656-3661, 1995
8. ERDOS EG: News about ACE, or, the separate lives of "siamese twin" domains. J Clin Invest 97:588, 1996
9. YANG HYT, ERDÖS EG, LEVIN Y: A dipeptidyl carboxypeptidase that converts angiotensin 1 and inactivates bradykinin. Biochim Biophys Acta 214:374-376, 1970
10. CHAO J, ZHANG JJ, LIN KF, CHAO L: Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl saltsensitive rats. Kidney Int 54:1250-1260, 1998
11. MADEDDU P, VIO CP, STRAINO S, et al: Renal phenotype of low kallikrein rats. Kidney lnt 59:2233-2242, 2001
12. GALLAGHER AM, YU H, PRINTZ MP: Bradykinin-induced reductions in collagen gene expression involve prostacyclin. Hypertens 32:84-88, 1998
13. SCHANSTRA JP, NEAU E, DROGOZ P, et al: In vivo bradykinin B2 receptor activation reduces renal fibrosis. J Clin Invest 110:371-379, 2002
14. AZIZI M, ROUSSEAU A, EZAN E, et al: Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest 97:839-844, 1996
15. ERDOS EG, SKIDGEL RA: The angiotensin I-converting enzyme. Lab Invest 56:345-348, 1987
16. WARD PE, SCHULTZ W, REYNOLDS RC, ERDOS EG: Metabolism of kinins and angiotensins in the isolated glomerulus and brush border of rat kidney. Lab Invest 36:599-606, 1977
17. HALL ER, KATO J, ERDÖS EG, ROBINSON CJG: Angiotensin I converting enzyme in the nephron. Life Sci 18:1299-1302, 1976
18. TAUGNER R, GANTEN D: The localization of converting enzyme in kidney vessels of the rat. Histochemistry 75:191-201, 1982
19. ANDERSON S, JUNG FF, INGELFINGER JR: Renal renin angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 265:F477-F486, 1993
20. WEI L, ALHENC-GELAS F, SOUBRIER F, et al: Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J Biol Chem 266:5540-5546, 1991
21. SUGA SI, PHILLIPS MI, RAY PE, et al: Hypokalemia induces renal injury and alterations in intrarenal vasoactive mediators that favor salt-sensitivity. Am J Physiol Renal Physiol 281:F620-F629, 2001
22. LOMBARDI DM, VISWANATHAN M, VIO CP, et al: Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent. Nephron 87:66-74, 2001
23. VIO CP, OLAVARRIA V, GONZALEZ C, et al: Cellular and functional aspects of the renal kallikrein system in health and disease. Biol Res 31:305-322, 1998
24. KAISSLING B, HEGYI I, LOFFING J, LEHIR M: Morphology of interstitial cells in the healthy kidney. Anat Embryol 193:303-318, 1996
25. CUSHMAN DW, CHEUNO HS: Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta 250:261-265, 1971
26. METZGER R, BOHLE RM, PAULS K, et al: Angiotensin-converting enzyme in non-neoplastic kidney diseases. Kidney Int 56:1442-1454, 1999
27. IKEMOTO F, SONG GB, TOMINAGA M, et al: Angiotensin converting enzyme predominates in the inner cortex and medulla of the rat kidney. Biochem Biophys Res Commun 144:915-921, 1987
28. MARCHETTI J, ROSEAU S, ALHENC-GELAS F: Angiotensin I converting enzyme and kinin-hydrolyzing enzymes along the rabbit nephron. Kidney Int 31:744-751, 1987
29. MEZZANO SA, DROGUETT A, BURGOS ME, et al: Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int 64(Suppl 86):S64-S70, 2003
30. MEZZANO SA, AROS C, DROGUETT A, et al: Renal angiotensin II upregulation and myofibroblast activation in human membranous nephropathy. Kidney Int 64(Suppl 86):S39-S45, 2003
31. LARGO R, GOMEZ-GARRE D, SOTO K, et al: Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertens 33:732-739, 1999
32. VON THUN, AM, VARI RC, EL-DAHR SS, NAVAR LG. Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol 35: F120-F128, 1994.
33. GUAN S, FOX J, MITCHELL KD, NAVAR LG: Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats. Hypertens 20:763-767, 1992
34. HARRISON-BERNARD LM, ZHUO J, KOBORI H, et al: Intrarenal AT1 receptor and ACE binding in AUG II-induced hypertensive rats. Am J Physiol Renal Physiol 282:F19-F25, 2002
35. TOKUYAMA H, HAYASHI K, MATSUDA H, et al: Differential regulation of elevated renal angiotensin II in chronic renal ischemia. Hypertens 40:34-40, 2002
36. CHALLAH M, NICOLETTI A, ARNAL JF, et al: Cardiac angiotensin converting enzyme overproduction indicates interstitial activation in renovascular hypertension. Cardiovasc Res 30:231-239, 1995
37. FALKENHAHN M, FRANKE F, BOHLE RM, et al: Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertens 25:219-226, 1995
38. PASSIER RC, SMITS JF, VERLUYTEN MJ, et al: Activation of angiotensin converting enzyme expression in infarct zone following myocardial infarction. Am J Physiol 269:H1268-H1276, 1995
39. SUN Y, WEBER KT: Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 28:851-858, 1996
40. RIEGER KJ, SAEZ-SERVENT N, PAPET MP, et al: Involvements of human plasma angiotensin converting enzyme in the degradation of the hemoregulatory peptide N-acetyl-Seryl-Aspartyl-Lysyl-Proline. Biochem J 296:373-378, 1993
41. RHALEB HE, PENG H, HARDING P, et al: Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline on DNA and collagen synthesis in rat cardiac fibroblasts. Hypertens 37:827-832, 2001
42. RHALEB HE, PENG H, YANG XP, et al: Long-Term Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline on left ventricular collagen deposition in rats with 2-Kidney, 1-Clip hypertension. Circulation 103:3136-3141, 2001
43. PENG H, CARRETERO OA, RAIJ L, et al: Antifibrotic effects of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline on the heart and kidney in aldosterone-salt hypertensive rats. Hypertens 37:794-800, 2001
44. POKHAREL S, RASOUL S, ROKS AJ, et al: N-acetyl-ser-asp-lys-pro inhibits phosphorylation of Smad2 in cardiac fibroblasts. Hypertens 40:155-161, 2002
45. LIU JM, LAWRENCE F, KOVACEVIC M, et al: The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo. Blood 101:3014-3020, 2003
46. EMANUELI C, MINASI A, ZACHEO A, et al: Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation 103:125-132, 2001
47. SILVESTRE JS, BERGAYA S, TAMARAT R, et al: Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B2 receptor pathway. Circ Res 89:678-683, 2001
48. FABRE JE, RIVARD A, MAGNER M, et al: Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation 99:3043-3049, 1999
49. JAFFA AA, VIO C, VELARDE V, et al: Induction of renal kallikrein and renin gene expression by insulin and IGF-1 in the diabetic rat. Diabetes 46:2049-2056, 1997
50. WOLF WC, YOSHIDA H, AGATA J, et al: Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure. Kidney Int 58:730-739, 2000
51. JOHNSON RJ, HERRERA-ACOSTA J, SCHREINER GF, RODRIGUEZ-ITURBE B: Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 346:913-923, 2002
52. LISS P, NYGREN A, ERIKSON U, ULFENDAHL HR: Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int 53:698-702, 1998
53. FINE LG, BANDYOPADHAY D, NORMAN JT: Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int 57(Suppl 75):S22-S26, 2000
54. OPARIL S, NARKATES AJ, JACKSON RM, ANN HS: Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats. J Appl Physiol 65:218-227, 1988
55. SAIJONMAA O, NYMAN T, KOSONEN R, FYHRQUIST F: Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor. Am J Physiol Heart Circ Physiol 280:H885-891, 2001
56. ENHOLM B, PAAVONEN K, RISITMAKI A, et al: Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14:2475-2483, 1997
57. JOHNSON RJ, GORDON KL, SUGA S, et al: Renal injury and salt-sensitive hypertension after exposure to catecholamines. Hypertension 34:151-159, 1999